Microneedling creates controlled micro-injury in living skin and may stimulate a wound-healing response. Its value depends on appropriate patient selection, an authorised device, disciplined infection prevention, correct technique and realistic outcomes. It is not a routine facial performed from a universal depth chart, and more aggressive treatment is not automatically more effective.
Exosomes are membrane-bound extracellular vesicles involved in cell-to-cell communication. They are scientifically interesting, but products marketed under the term vary widely in source, composition, purification, characterisation and regulatory status. Early dermatology studies are encouraging in some settings, yet they do not establish that all exosome products are safe, effective or suitable for use with microneedling.
This programme brings both fields together responsibly. Participants learn the foundations of mechanical microneedling, structured consultation, device-led parameter selection, sterile workflow, treatment endpoints, aftercare and complication recognition. They also learn how to examine an exosome-related product dossier, distinguish evidence from marketing and decide when a proposed combination should proceed, be modified, be referred for governance review or not be performed.
The practical component develops transferable clinical habits. Depending on the confirmed edition and product clearance, it may include simulation, device setup, cartridge insertion, treatment mapping, supervised model work and documentation. It does not automatically authorise the application, infusion or injection of any exosome-based product.
Hold the professional registration, licence or qualification required for the intended activity in their jurisdiction.
Have foundational knowledge of skin anatomy, consultation and infection prevention.
Be able to recognise when a presentation requires medical review or referral.
Provide evidence of relevant professional status if requested.
Complete any required pre-learning and review the device/product information supplied for the edition.
Participate within their existing scope, insurance and employer or clinic policy.
Skin anatomy, barrier function and controlled wound-healing response
Evidence, limitations and appropriate claims for professional microneedling
Exosomes and extracellular vesicles: terminology, biology and unresolved questions
Critical appraisal of exosome-based product quality, source and documentation
Regulatory and professional-scope checkpoints before combined use
Patient consultation, history, expectations and documented treatment planning
Indications, precautions, contraindications and referral thresholds
Device inspection, sterile cartridge handling and parameter selection from the IFU
Infection prevention, aseptic workflow, sharps and environmental controls
Safe treatment sequencing, endpoint recognition and stop criteria
Considerations across skin types, anatomical areas and pigment risk
Pre-treatment preparation, aftercare and recognition of complications
Supervised demonstration and practical skills stations
Case-based decision-making and accurate clinical documentation
Clear distinction between course completion and professional authorisation
The programme opens with clinically relevant skin anatomy. Participants connect epidermal barrier function, dermal structure, vascularity, inflammation and wound-healing phases to what happens during mechanical microneedling. The aim is not to memorise a fixed depth for each concern, but to understand why anatomy, device design and individual risk determine the plan.
Evidence is then examined by indication. Participants learn where microneedling has supportive clinical evidence, where results are less certain and why study outcomes cannot be transferred automatically between devices, protocols, populations or combination products. Treatment goals are translated into measurable baseline findings, photographs where consented and realistic follow-up plans.
The exosome module explains extracellular-vesicle terminology, proposed signalling mechanisms and the difference between laboratory plausibility, early clinical studies and established patient benefit. Participants examine questions that a responsible clinic should ask: What is the source? How was the material isolated and characterised? What does the certificate of analysis actually confirm? Is sterility relevant and demonstrated? What are the storage and reconstitution requirements? What route and claims are legally supported? Has the device manufacturer authorised combined use?
Consultation training covers medical and aesthetic history, current skin condition, previous procedures, medicines, allergy, healing and scarring history, infection risk, pigment response, expectations and ability to follow aftercare. Participants practise recognising cases requiring postponement, medical review or referral. Consent includes material risks, alternatives, uncertainty and the specific status of any adjunctive product.
The practical workflow begins with treatment-area preparation, hand hygiene, PPE, clean and contaminated zones, device inspection, single-use sterile cartridge verification and sharps disposal. Learners use the actual device IFU to select permitted parameters. They plan anatomical zones, protect vulnerable structures and monitor skin response rather than chasing a dramatic endpoint.
Technique teaching covers controlled contact, pressure, movement, overlap, product handling, time management and stop criteria. The faculty demonstrates how to avoid contamination between the device, product, gloves, controls and treatment field. Any product-assisted component follows a pre-approved protocol; if approval is absent, the exercise remains simulated.
Aftercare focuses on barrier recovery, gentle care, sun protection, avoidance of irritation and clear instructions on expected effects versus warning signs. Participants learn a structured response to prolonged erythema, increasing pain, pustules, blistering, pigment change, suspected infection, allergic or granulomatous reaction and other unexpected outcomes, including documentation, escalation and referral.
The programme concludes with case planning and supervised skills assessment. Learners justify whether to treat, postpone or refer; choose a compliant device pathway; evaluate an adjunctive product; explain consent; organise infection controls; record parameters and endpoints; and create a proportionate follow-up plan.
This programme is intended for appropriately qualified healthcare or aesthetic practitioners whose existing professional scope and local rules allow them to assess patients and undertake, assist with or govern professional microneedling procedures.
It may be relevant to doctors, nurses and other regulated healthcare professionals, as well as appropriately licensed aesthetic practitioners where local law permits. Attendance suitability must be confirmed before enrolment. The programme is not designed to convert an unlicensed beginner into an independent clinical practitioner.
